Search
Spotlight
In-person and virtual events just for HCPs
In-person and virtual events just for HCPs
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
Pipeline Report
OncClub
All Oncology News
Pipeline Report
Media
Insights
Medical World News
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Insights
Medical World News
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Partners
Publications
Oncology Live®
Oncology Fellows
Supplements and Featured Publications
All Publications
Oncology Live®
Oncology Fellows
Supplements and Featured Publications
All Publications
CME/CE
Resources
Interactive Tools
Learning Modules
Presentations
Sponsored
Interactive Tools
Learning Modules
Presentations
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
In-person and virtual events just for HCPs
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Pre-Conference Perspectives on Hematologic Malignancies - Episode 1
Pre-Conference Perspectives on Hematologic Malignancies
December 6, 2017
Now Viewing
EP. 1: Pre-Conference Perspectives on Hematologic Malignancies
EP. 2: Hodgkin Lymphoma: Upfront Brentuximab Vedotin + AVD
EP. 3: New Data for Mantle Cell Lymphoma
EP. 4: NHL Studies: CAR T Therapy, Rituximab Maintenance, & PD-L1
EP. 5: Acute Myeloid Leukemia: Novel Targeted Therapies
EP. 6: AML Studies: FLT3 Inhibitors
EP. 7: AML Studies: BiTE Antibodies and Age for Transplant
EP. 8: KRd for High-Risk Smoldering Myeloma
EP. 9: Daratumumab for Smoldering Myeloma
EP. 10: Key Studies in Newly-Diagnosed Multiple Myeloma
EP. 11: Phase III Data for Relapsed/Refractory Myeloma
EP. 12: MRD Testing in Hematologic Malignancies
EP. 13: Q & A Session for Hematologic Malignancies
EP. 14: What You Need to Know: Hematologic Malignancies
Related Content:
Pre-Conference Perspectives on Hematologic Malignancies
Hematologic Oncology
Non-Hodgkin Lymphoma
Multiple Myeloma
Mantle Cell Lymphoma
Precision Medicine in Oncology®
OncLive’s September Roundup of Key FDA Approvals in Oncology
Dr Chari on the Risks and Benefits Associated With Earlier CAR T Use in R/R Multiple Myeloma
Emavusertib-Focused Research Is Poised to Expand the PCNSL Treatment Paradigm